/
Ophthalmic goods company · DE · FY ends Oct · Revenue $4.15B · 17.19% margin · $491M FCF
16.69% operating margin is respectable but not wide. ROIC at 4.46%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 5.1%, steady but not accelerating.
Net debt of $2.72B represents 6.3x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$4.15B
▲ +5.1% YoY
Net Income (TTM)
$401M
▼ -4.4% YoY
Op. Margin
17.19%
▼ -1.4pp YoY
ROIC
4.60%
▼ -0.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$491M
▲ +50.5% YoY
Op. Cash Flow (TTM)
$866M
▲ +12.2% YoY
Net Debt
$3.00B
Cash & Equiv.
$125M
5Y CAGR: +11.0%
5Y CAGR: +19.7%
Continue Research